Loading clinical trials...
Loading clinical trials...
Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer: A Feasibility Pilot Study
Conditions
Interventions
Nursing Educational Intervention
Start Date
September 1, 2010
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
June 26, 2012
NCT06498635
NCT06066138
NCT06305754
NCT07336732
NCT05692635
NCT05198830
Lead Sponsor
Dana-Farber Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions